Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 585-589

  Gieffers, Jens ^a   Pohl, Daniela ^b   Treib, Johannes ^c   Dittmann, Rike ^a   Stephan, Christoph ^d   Klotz, Karl ^a   Hanefeld, Folker ^b   Solbach, Werner ^a   Haass, Anton ^e   Maass, Matthias ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Westpfalz Klinikum GmbH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA;

ARTICLE; BACTERIUM CULTURE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHILD; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; POLYMERASE CHAIN REACTION;

EID: 0035022769     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1020     Document Type: Article

References (15)

1. Ewing C, Bernard C. Insights in the etiology and pathogenesis of multiple sclerosis. Immunol Cell Biol 1998;76:47-54.
2. Sriram S, Stratton C, Yao S, et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999;46:6-14.
3. Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998;50:521-522.
4. Grayston, JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-763.
5. Boman J, Soderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular diseases and in middle-aged blood donors. J Infect Dis 1998;178:274-277.
6. Al-Younes HM, Rudel T, Meyer TF. Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol 1999;1: 237-247.
7. Wong YK, Dawkins KD, Ward ME. Circulating Chlamydia pneumoniae DNA as predictor of coronary artery disease. J Am Coll Cardiol 1999;34:1435-1439.
8. Guglielminotti J, Lellouche N, Maury E, et al. Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection. Clin Infect Dis 2000;30:209-210.
9. Haidl S, Ivarsson S, Bjerre I, Persson K. Guillain-Barre syndrome after Chlamydia pneumoniae infection. N Engl J Med 1992;20:576-577.
10. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998;187:23-42.
11. Boman J, Roblin M, Sundström P, et al. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000;54:265.
12. Layh-Schmitt G, Bendl C, Hildt U, et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol 2000;47:652-655.
13. Maass M, Bartels C, Engel P, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. JACC 1998;31:823-827.
14. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J Clin Microbiol 2000;38:881-882.
15. Tong CYW, Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 1993;46:313-315.